newsfilter
← Latest News
GlobeNewswire·

Heat Biologics Announces Formation of Biothreat Advisory Board

DURHAM, N.C., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, announces it has commenced developmen